MCK - McKesson Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
136.85
+1.29 (+0.95%)
As of 2:50PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close135.56
Open135.37
Bid136.75 x 800
Ask136.78 x 800
Day's Range134.54 - 136.93
52 Week Range106.11 - 160.87
Volume735,194
Avg. Volume1,816,423
Market Cap26.251B
Beta (3Y Monthly)1.46
PE Ratio (TTM)N/A
EPS (TTM)-1.58
Earnings DateJan 30, 2019 - Feb 4, 2019
Forward Dividend & Yield1.56 (1.16%)
Ex-Dividend Date2019-02-28
1y Target Est137.31
Trade prices are not sourced from all markets
  • Is McKesson Corporation (MCK) a Great Stock for Value Investors?
    Zacks4 days ago

    Is McKesson Corporation (MCK) a Great Stock for Value Investors?

    Is McKesson Corporation (MCK) a great pick from the value investor's perspective right now? Read on to know more.

  • CNBC7 days ago

    FDA issues warning letter to drug distributor McKesson for allegedly shipping 'illegitimate' opioid products

    The Food and Drug Administration has sent a warning letter to major drug distributor McKesson. The FDA accuses McKesson of failing to identify, investigate and stop people from tampering with its opioid shipments. The Food and Drug Administration  said Tuesday it has sent a warning letter to drug distributor McKessson MCK for allegedly shipping "illegitimate" opioid products and failing to properly handle and investigate the incidents.

  • Bay Area fintech opens office in Texas
    American City Business Journals7 days ago

    Bay Area fintech opens office in Texas

    The company’s site selection for its first office outside California highlights how prized Bay Area tech companies are for economic development, even in some of the nation’s largest cities.

  • Cardinal Health Strong on Pharmaceutical, Competition Rife
    Zacks7 days ago

    Cardinal Health Strong on Pharmaceutical, Competition Rife

    Cardinal Health (CAH) is on track to deliver targeted annualized cost savings of $100 million in fiscal 2019.

  • The World's Top 10 Health Care Companies (UNH, MDT)
    Investopedia11 days ago

    The World's Top 10 Health Care Companies (UNH, MDT)

    Discover the world's top 10 health care companies according to market capitalization, including a brief summary of each.

  • GlobeNewswire11 days ago

    Recent Analysis Shows Amerco, McKesson, Ophthotech, IQVIA, Highwoods Properties, and ABM Industries Market Influences — Renewed Outlook, Key Drivers of Growth

    NEW YORK, Feb. 08, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • Markit11 days ago

    See what the IHS Markit Score report has to say about McKesson Corp.

    McKesson Corp NYSE:MCKView full report here! Summary * Perception of the company's creditworthiness is negative but improving * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for MCK with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MCK. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding MCK totaled $14.26 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator with a strengthening bias over the past 1-month. MCK credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Here's Why You Should Invest in McKesson (MCK) Stock Now
    Zacks13 days ago

    Here's Why You Should Invest in McKesson (MCK) Stock Now

    McKesson's (MCK) solid prospects in the pharmaceutical and medical supplies distribution market look promising.

  • MCK vs. ALGN: Which Stock Should Value Investors Buy Now?
    Zacks15 days ago

    MCK vs. ALGN: Which Stock Should Value Investors Buy Now?

    MCK vs. ALGN: Which Stock Is the Better Value Option?

  • Are Investors Undervaluing McKesson (MCK) Right Now?
    Zacks15 days ago

    Are Investors Undervaluing McKesson (MCK) Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Drug distributors’ stocks are caught in the middle of the opioid epidemic
    MarketWatch17 days ago

    Drug distributors’ stocks are caught in the middle of the opioid epidemic

    Of these deaths, 47,600 (67.8%) involved opioids and 17,000 involved prescription opioids (24% of total overdose deaths). According to the National Institute on Drug Abuse, in the late 1990s, pharmaceutical companies reassured the medical community that patients would not become addicted to prescription opioid pain relievers, and healthcare providers began to prescribe them at greater rates. Today pharma distributors are used as scapegoats for the opioid epidemic — not because they are guilty but because they have money and they are “drug distributors.” They are dragged through the same mud as were the tobacco companies and British Petroleum (after it spilled millions of gallons of oil into the Gulf of Mexico).

  • Thomson Reuters StreetEvents18 days ago

    Edited Transcript of MCK earnings conference call or presentation 31-Jan-19 10:00pm GMT

    Q3 2019 McKesson Corp Earnings Call

  • McKesson Deals With Flat Earnings
    Motley Fool18 days ago

    McKesson Deals With Flat Earnings

    The drug distributor remains confident about the full fiscal year.

  • McKesson (MCK) Beats on Q3 Earnings, Gains From Solid View
    Zacks18 days ago

    McKesson (MCK) Beats on Q3 Earnings, Gains From Solid View

    McKesson (MCK) gains from the U.S. Pharmaceutical and Specialty Solutions segment in third-quarter fiscal 2019.

  • Morningstar18 days ago

    Steady Top-Line Growth for McKesson

    The wide-moat firm's core drug distribution business posted gains of 6% in results that were largely in line with expectations.

  • McKesson (MCK) Q3 2019 Earnings Conference Call Transcript
    Motley Fool18 days ago

    McKesson (MCK) Q3 2019 Earnings Conference Call Transcript

    MCK earnings call for the period ending December 31, 2018.

  • McKesson (MCK) Q3 Earnings and Revenues Beat Estimates
    Zacks19 days ago

    McKesson (MCK) Q3 Earnings and Revenues Beat Estimates

    McKesson (MCK) delivered earnings and revenue surprises of 6.92% and 1.69%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

  • MarketWatch19 days ago

    McKesson stock ticks higher after earnings beat

    McKesson Corp. shares ticked higher in the extended session Thursday after the health-care supply-chain management company's results topped Wall Street estimates. McKesson shares rose 0.6% after hours, following a 2.6% rise to close the regular session at $128.25. The company reported fiscal third-quarter net income of $469 million, or $2.40 a share, compared with $903 million, or $4.33 a share, in the year-ago period. Adjusted earnings were $3.40 a share. Revenue rose to $56.21 billion from $53.62 billion in the year-ago quarter. Analysts surveyed by FactSet had forecast earnings of $3.15 a share on revenue of $55.06 billion. For the year, McKesson narrowed its forecast adjusted earnings to a range of $13.45 to $13.65 from the previous range of $13.20 to $13.80 a share. Analysts had forecast earnings of $13.40.

  • Associated Press19 days ago

    McKesson: Fiscal 3Q Earnings Snapshot

    The San Francisco-based company said it had profit of $2.40 per share. Earnings, adjusted for one-time gains and costs, came to $3.40 per share. The results topped Wall Street expectations. The average ...

  • Business Wire19 days ago

    McKesson Reports Fiscal 2019 Third-Quarter Results

    SAN FRANCISCO-- -- Revenues of $56.2 billion for the third quarter, up 5% year over year. Third-quarter GAAP earnings per diluted share from continuing operations of $2.41. Third-quarter Adjusted Earnings per diluted share of $3.40, flat year over year. Fiscal 2019 Outlook: Adjusted Earnings of $13.45 to $13.65 per diluted share. McKesson Corporation today reported that revenues for the third quarter ...

  • Moody's20 days ago

    Change Healthcare Holdings LLC -- Moody's downgrades Change Healthcare's CFR to B2, facility ratings to B1/Caa1; outlook stable

    Rating Action: Moody's downgrades Change Healthcare's CFR to B2, facility ratings to B1/Caa1; outlook stable. Global Credit Research- 30 Jan 2019. Nearly $6.5 billion of rated debt affected.

  • Medical Products' Earnings Lineup for Jan 31: EW, BAX & More
    Zacks20 days ago

    Medical Products' Earnings Lineup for Jan 31: EW, BAX & More

    Let's take a look at the factors that are likely to influence the earnings results of a few Medical Products bigwigs within the broader Medical space.

  • Will Core Business Units Boost McKesson's (MCK) Q3 Earnings?
    Zacks22 days ago

    Will Core Business Units Boost McKesson's (MCK) Q3 Earnings?

    McKesson (MCK) expects to gain from solid segmental performances in third-quarter fiscal 2019.

  • Barrons.com22 days ago

    The 15 Companies Least Vulnerable to Climate Change Risk

    There is growing recognition of the risks that climate change poses to companies and their investors. But some companies don’t have nearly as much to worry about as others.

  • Does FedEx look good here? What's the deal with McKesson? Buy Abbvie?
    CNBC Videos11 days ago

    Does FedEx look good here? What's the deal with McKesson? Buy Abbvie?

    The "Halftime Report" traders take viewer questions on FedEx, McKesson, Abbvie, Foot Locker and Starbucks.